Health Care & Life Sciences » Pharmaceuticals | Karessa Pharma Holding AB

Karessa Pharma Holding AB

Karessa Pharma Holding AB
Stock Exchange First North Sweden
EPS
SEK1.41
Market Cap
SEK56.76 M
Shares Outstanding
11 M
Public Float
-

Profile

Address
Lahällsvägen 48
Täby AB 183 30
Sweden
Employees -
Website http://www.karessa.se
Updated 09/14/2018
Karessa Pharma Holding AB engages in the development and commercialization of products in the therapeutic area of erectile dysfunction. Its projects include K-01, K-02, and K-03. The company was founded by Fredrik Hubinette on September 11, 2013 and is headquartered in Täby, Sweden.

Financials

View All

Ulf Lindberg
Chairman
Michael Brobjer
Chief Executive Officer & Director